Diagnostics of Precancerous and Cancerous Lesions

Embed Size (px)

Citation preview

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    1/133

    Presented by:Dr. Kush Pathak

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    2/133

    Introduction

    Classification of Precancerous lesions and

    Conditions Detection techniques

    Advanced diagnostic methods

    Conclusion References

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    3/133

    Oral cancer is sometimes preceded by clinically visible lesions

    which are noncancerous to begin with and which have therefore

    been termed precancerous or premalignant. WHO divided this

    premalignant state into two:

    Precancerous lesions

    Precancerous condition ( Pindborg 1980)

    The ability to diagnose premalignant state is critical to the battleagainst oral cancer, so that it can be managed conservatively with

    minimal surgical morbidity and 100% survival.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    4/133

    The most important and widely used method of evaluating the

    malignant potential of oral precancerous lesions and conditions is

    by a conventional microscopical study of epithelial dysplasia.

    Advances in molecular diagnosis suggest that genetic markers of

    precancerous changes are likely detectable before clinical and

    histopathologic changes can be identified making it necessary todevelop these methods for early diagnosis and treatment.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    5/133

    Precancerous lesion - (WHO 1978) is a morphologically alteredtissue in which cancer is more likely to occur than in its apparently

    normal counterpart.

    Clinical classification Leukoplakia

    Erythroplakia Proliferative Verrucous leukoplakia

    palatal keratosis with reverse smoking

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    6/133

    Histological classification Squamous epithelial dysplasia

    Squamous cell carcinoma

    Solar keratosis

    Precancerous condition: (WHO 1978) is defined as a generalizedstate associated with a significantly increased risk of cancer.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    7/133

    Sideropenic dysphagia

    lichen planus

    Oral submucous fibrosis

    Syphilis

    Discoid lupus erythematosus

    Xeroderma pigmentosa

    Epidermolysis bullosa

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    8/133

    Clinical examination Diagnostic adjuncts

    Cytology

    Brush cytology

    Liquid cytology

    Tissue fluorescence

    Vital staining Diagnostic methods

    Biopsy Fine needle aspiration

    Sentinel node biopsy

    Imaging

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    9/133

    Cytochemical and molecular methods Nucleolar organizing regions

    Abnormal DNA segregation (DNA aneuploidy)

    Loss of heterozygosity

    Advanced Molecular methods Molecular methods

    Polymerase chain reaction

    Filter hybridization

    In situ hybridization

    Fluorescent in situ hybridization

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    10/133

    Comparative genomic hybridization

    Complemantry DNA (cDNA) microarrays

    Flow cytometry

    Immunologic methods Immunohistochemistry

    Immunofluorescency

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    11/133

    Should include a thorough head and neck & intraoral examination,

    with examination of the lymph nodes and visual examination,

    palpation of the oral mucosa.

    The location, size, border, color and surface characteristics of the

    lesion should be noted.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    12/133

    A variety of aids to the diagnosis of oral precancerous and

    cancerous lesions have been developed in past few years. Increased

    use of these adjunctive tools by dentists would likely improve early

    cancer detection. However proper case selection and correct

    performance of the test itself is critical to the sensitivity and

    specificity of its result.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    13/133

    This is the study of cells which exfoliate or abrade from the body

    surface.

    Procedure:- Involves stroking the lesion gently but firmly with a wet wooden

    tongue blade or cotton tip applicator.

    The collected cells are smeared on a frosted slide and immediately

    fixed with alcohol ether. After drying the glass slide is packagedand sent to an oral pathology laboratory for staining.

    Cell slides are examined for benignancy or malignancy.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    14/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    15/133

    The Cytological smear falls in one of the five classes

    Class I (normal) indicates that only normal cells were seen Class II (atypical) indicates the presence of minor atypia but no

    evidence of malignant changes

    Class III (indeterminate) cells display wider atypia that may besuggestive of cancer, may represent precancerous lesions orcarcinoma in situ. Biopsy is recommended in such cases

    Class IV (suggestive of cancer) few cells with malignantfeatures or many cells with borderline. Biopsy is mandatory.

    Class V (positive of cancer) cells are obviously malignant.Biopsy is mandatory.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    16/133

    Advantage: Quick, simple, painless and bloodless procedure Helps as a check against false negative biopsies Especially helpful in follow-up detection of recurrent carcinoma in

    previously treated cases Screening lesion where biopsy is not warranted

    Disadvantages: Presence and extent of invasion can not be assessed

    Scarcity of viable surface cells Biopsy is indicated in all clinically suspicious lesions even on

    negative result Has high false negative results

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    17/133

    Introduced in 1999 as an alternative to conventional Exfoliative

    cytology for suspicious epithelial lesions.

    Procedure :

    Transepithelial cell samples are obtained by twirling a patented spiralshaped stiff nylon bristle brush on the lesion.

    Collected cells are transferred to a bar coded, clear glass slide and a

    supplied pouch of alcohol fixative is immediately poured over the

    slide.

    The specimen is mailed. Results of brush cytology specimens are

    classified into one of four categories:-

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    18/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    19/133

    Inadequateincomplete transepithelial sample Negativeno epithelial abnormality Atypicalabnormal epithelial changes Positive definitive cellular evidence of epithelial dysplasia or

    carcinoma

    For atypical and positive results follow up scalpel biopsy is

    recommended. In case of a negative result clinical follow up ofpersistent oral lesions is recommended.

    Scuibba et al reported 100% sensitivity with 100% specificity for

    positive results and 92.9% specific results in 945 patients.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    20/133

    Advantages: Full thickness sample Easy to use Useful alternative in patients who refuse a scalpel biopsy

    In combination with vital staining may be useful for samplingmultiple areas of large lesions or in follow up patients.Disadvantages:

    Specimens have to be processed in commercial processinglaboratory

    Not all of the harvested transepithelial cells are transferred to theglass slide

    Expensive

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    21/133

    Provides a clearer and more attractive presentation.

    Procedure: Transepithelial cells are harvested with a nylon bristle brush that is

    then immersed and twirled in a liquid preservative container; the

    brush can be disposed of or included in the specimen.

    The liquid container is sent to the oral pathology laboratory where

    a patented machine filters the harvested cells from debris and lays

    the cells in monolayer on a glass slide, followed by staining and

    examination.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    22/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    23/133

    Advantages: Better representation of collected lesional cells

    Easier interpretation since there is a monolayer of cells with

    elimination of blood and debris

    False positive and false negative results lessened.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    24/133

    Used in combination with conventional visual oral mucosal

    examination by healthcare providers to improve identification,

    evaluation and monitoring of oral mucosal abnormalities. Several

    different products designed for this technique have been marketed

    including:

    Vizilite, now available as Vizilite plus or vizilite with Tblue

    marking system. MIcrolux DL

    VELscope (visually enhanced lesion scope)

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    25/133

    Vizilite Is a single use product that consists of an acetic acid rinse, retractor

    and light stick. The patient rinses with vizilite acetic acid solution

    and expectorates.

    Acetic acid wash helps to remove surface debris and causes theepithelial cells to dehydrate slightly, increasing the prominence of

    their nuclei.

    The vizilite light stick is activated by bending until the innercapsule breaks.

    The examiner shakes until it glows (activated chemiluminescence)

    then inserts the light stick into the hollow end of the retractor.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    26/133

    After dimming the lights, the oral cavity is examined using vizilite.Under blue whit illumination normal epithelium appears lightbluish in color, whereas abnormal epithelium appears distinctlywhite.

    Vizilite plus: Consists of the same device packaged together with atolonium chloride solution. The stain is intended for use as amarking dye to help highlight lesions identified with light source.

    Velscope: is an alternating current powered portable, reusablelight source and uses filters to block the reflected blue light to allowthe visualization of the natural tissue fluorescence.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    27/133

    It is intended to be used as an adjunct to traditional oral

    examination to enhance the visualization of oral mucosal

    abnormalities that may not be apparent bynaked eye.

    It is intended to be used by surgeons to identify diseased tissue

    around clinically apparent lesion and thus aid in determining the

    appropriate margin for surgical excision.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    28/133

    The clinician is then able to differentiate different fluorescence

    response ofnormal and abnormal tissue. Healthy tissue appears as

    bright apple green glow while suspicious regions are identified by a

    loss of fluorescence which thus appears dark.

    In a study by Lane et al(2006) using histology as gold standard, the

    device achieved a sensitivity of 98% and a specificity of 100% . Theauthors stated that this device has a potential as an adjunct to

    convention white light screening.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    29/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    30/133

    Advantage: Vizilite is simple to use

    VELscope is portable, multiuse device and simple to use

    Disadvantage: Vizilite plus is costly and light stick can only be activated once

    VELscope unit is expensive and its durability has not been proven

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    31/133

    Toludine blue or tolonium chloride.

    In 1964, Nibel amd Chomet first reported on the use the use oftoludine blue as a vital tissue stain to aid in the early detection of

    oral precancerous and malignant lesions.

    The chemical name of the dye used is toludine chloride. It is a basicmetachromatic stain that binds to the DNA.

    Although not cancer specific, it stains mitochondrial DNA, alteredDNA in Premalignant/malignant lesions and cells with increasedamounts of DNA.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    32/133

    The practitioners swab the blue dye onto a suspicious oral lesionand based on its retention and changes in blue tint, determine with

    greater reliability whether to proceed to biopsy.

    Studies from 1964 to 1992, show that toludine blue exhibitsensitivity that ranged from 86% to 100% with a specificity rangingfrom 63% to 100%.

    Recent studies have also shown that TB positivity is higher in OPL

    that show loss of heterozygosity at chromosome regions associatedwith development of squamous cell carcinoma (3p,17p).

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    33/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    34/133

    Despite the growing number of adjuncts available to assist in theclinical detection of lesions with uncertain biologic potential,surgical biopsy remains by far the most popular method ofobtaining a final tissue diagnosis.

    Once a diagnosis is established, additional studies (includingimaging modalities) may be needed to determine the stage ofdiseases and to guide the treatment plan development.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    35/133

    It is the removal of tissue from the living organism for the purposesof microscopic examination and diagnosis. The different methods ofbiopsy are:Excision biopsy: The goal of excision biopsy is to obtain theentire abnormality for histopathologic examination and toprovide definitive treatment by the total removal of the lesion.Adequate deep and lateral margins of normal appearing tissuemust be excised to ensure that no remnants of the lesionremain as a potential source of recurrence. It is reserved forclinically benign and precancerous mucosal lesions that areless than 2 cm in diameter.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    36/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    37/133

    Incisional Biopsy Most suspicious lesions of the oral cavity arediagnosed through an incision biopsy, where a portion of theabnormal surface tissue is removed for histopathologicexamination.

    The tissue samples should include the most clinically suspiciousportion of the lesion, including areas of erythroplakia, speckledleukoplakia, surface granularity or ulceration.

    Application of TB stain may be useful in highlighting suspiciousareas.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    38/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    39/133

    Punch biopsy - Punch is a soft tissue sampling instrument having a circular cutting

    edge of varying diameter.

    Deep biopsies in the areas like palate can be relatively simple to

    obtain. But the disadvantages are the difficulty in controlling the sample

    depth and necessary subsequent use of scalpel or scissors.

    The tissue sample should be studied histopatholgically for epithelialdysplasia which is assigned to histopathological changes associatedwith an increases risk of malignant development. The individualcellular changes are referred to as atypia.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    40/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    41/133

    The criteria used for diagnosing epithelial dysplasia (Pindborg et al1997) are:

    Loss of polarity of basal cells

    The presence of more than one layer of cells having a basaloid

    appearance

    Increased nuclear cytoplasmic ratio Drop shaped rete ridges

    Irregular epithelial stratification

    Increase number of mitotic figures

    Mitotic figures that are abnormal in form

    The presence of mitotic figures in the superficial half of the

    epithelium

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    42/133

    Cellular and nuclear pleomorphism

    Nuclear hyperchromatism

    Enlarged nuclei

    Loss of intercellular adherence

    Keratinization of single cell or cell groups in the prickle cell layer

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    43/133

    Brandwein Gensler et al 2005 proposed a histologic risk assessmentsystem based on:

    Perineural invasion greater than 1mm involving nerves

    Lymphocytic response Worst pattern of invasion at interface

    Imaging Evaluation of deep tissue involvement of oral cancer,presence of cervical lymphadenopathy and future evaluation of

    primary tumor often requires use of several imaging modalities.

    Imaging options include panoramic radiography, CT, MRI andpositron emission tomography.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    44/133

    CT scan with intravenous contrast is the most common imagingmodalityused in the assessment ofdeep tissue extension of tumorsof oral cavity.

    Advantage: Clearly demonstrates bone changes and tumor invasion More sensitive than MRI for lymphadenopathy Lower cost and good soft tissue contrast Better tolerated than MRI by patients

    Disadvantage: Radiation dose Beam hardening artifact attributable to dental amalgam

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    45/133

    MRI is superior in providing soft tissue details has multiplanarimaging capability and can better demonstrate intracranialextension of the tumor.

    Disadvantage: Bony details are not clear Imaging times are longer Can not be used in patients who can not easily lie still or are

    claustrophobic

    Ultrasound can help in evaluation of neck nodes. However boneinvolvement can not be assessed as bone does not transmit sound.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    46/133

    Sentinel node biopsy This procedure is intended to identify micrometastatic disease

    within a sentinel node considered most likely to drain the tumor

    bed and receive initial metastatic deposits from the primary

    malignancy.

    Represents a less invasive means of providing staging information

    for the patient with oral cancer. So that not all the patients have to

    undergo lymphadenopathy.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    47/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    48/133

    Procedure Preoperative lymphoscintigraphy

    Intraoperative lymphatic mapping

    Excision of sentinel lymph nodes

    Pathologic evaluation of sentinel lymph nodes

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    49/133

    Recent advances in molecular studies show that alterations at DNA

    level precede microscopic morphologic changes in pre cancer and

    cancer.

    Evaluation of these markers may help in early characterization of

    oral epithelial dysplasia and squamous cell carcinoma.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    50/133

    Nucleolar organizing regions: These are loops of ribosomal DNA located on the short arms of

    chromosome 13,14,15,21 and 22 & are associated with acidic nonhistonic proteins that can be visualized by silver stainingtechniques.

    Number and size of AgNORs correlate positively with cellularproliferation.

    Mean AgNOR counts differ significantly between nondysplasticclinical leukoplakia with a sensitivity of 75 %.

    Limitation with the technique includes the time and effort requiredto perform the study manually as well as staining variability andcounting subjectivity.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    51/133

    DNA aneuploidy - (abnormal DNA segregation)

    Abnormal chromosomal segregation resulting in aneuploidy can be

    a marker for neoplastic transformation. Studies have reported an

    association of ploidy status in dysplastic lesions with progressionrisk of oral pre cancer.

    Lowest risk was associated with diploid lesions, tetreploid lesions

    had intermediate risk and aneuploid lesions show greater risk.

    (Lipmann SM, Hong WK 2001)

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    52/133

    Accordingly a staging system of oral PML was proposed by Zangand Rosin with both pathologic and genetic findings.

    P1 no or mild dyslasia, P2 moderate dysplasia, P3 severe dysplasiaG1 low risk, G2 intermediate, G3 high risk

    Stage (cancer risk) Pathology P % genetic Gpattern

    1 P1+G1

    2 P2+G1,P1+G2,P2+G2

    3 P3+G1,P3+G2, ANY P withG3

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    53/133

    DNA alteration (loss of heterozygosity) The progression of oral epithelium from a benign to malignant

    process begins at genetic level and is ultimately expressed at thecellular and clinical level.

    Carcinogenesis does not result from a single area of DNA damage

    but is a multistep process that requires an accumulation ofseveralDNA alterations collectively resulting in an uncontrolled neoplastic

    growth.

    Recent studies show that loss of allelic balance or LOH inprecancerous lesions is found in the 3p and 9p regions.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    54/133

    For a given lesion the risk for progression to cancer can be

    classified into

    Low risk if no LOH is found.

    Intermediate if LOH at 3p & 9p is found.

    High if LOH at 3p & 9p is found along with additional genetic

    damages.

    The diagnosis of cancer and many other diseases is fundamentally

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    55/133

    The diagnosis of cancer and many other diseases is fundamentallybased on the microscopic study of cells and tissues and remains thestandard by which all other diagnostic tests are measured.

    The methods include

    Molecular methods Polymerase chain reaction Filter hybridization

    In situ hybridization

    Fluorescent in situ hybridization

    Comparative genomic hybridization

    Complemantry DNA (cDNA) microarrays

    Flow cytometry

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    56/133

    Immunologic methods Immunohistochemistry

    Immunofluorescency

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    57/133

    DNA & RNA extraction: Currently all pathologic materials aresuitable for nucleotide extraction.

    The steps involved in DNA extraction are:

    Lysis of the cell usually performed with a detergent such assodium dodecy sulfate.

    Proteniase K is used to both release the DNA from thechromatin and to destroy DNAases. DNAases can also bedestroyed through their heat sensitivity(65 degree for 15 min)

    or with high concentration of EDTA. Cellular macromolecules are removed by extraction of the

    sample in phenol or chloroform or both, which also functionsto remove any excess proteinase.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    58/133

    After this extraction step, the DNA is concentrated byethanolprecipitation in the presence of acetate salts.

    The DNA is then brought into the solution with a buffer or

    distilled water and its concentration is assessed bymeasurement of its optical density of the solution at awavelength of 260nm.

    The sample is then ready for further processing or it can bestored for long periods of time. If stored for a period up to 1

    year, a 4 degree C refrigerator is sufficient, but for longerperiod a 20 degree C freezing is required.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    59/133

    The steps involved in RNA extraction are

    RNA extraction is complicated by the need to removeubiquitously present RNAases which may be endogenous or

    exogenous, or both Guanidium isothiocyanate (GITC) is the most effective reagent

    for RNA extraction.

    RNA needs to store at much lower temperature of70 degreeC.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    60/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    61/133

    A probe refers to a stretch of nucleotides that is used to detect a

    specific region of DNA or RNA.

    Those derived from native DNA are known as genomic probes and

    may include both the exons and introns.

    A probe derived from RNA is a cDNA probe and recognizes only

    exons.

    Oligonucleotide probes are formed in the laboratory and are much

    shorter that the other two.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    62/133

    Probes need to be further manipulated by the incorporation of a

    label, allowing for the detection of the specific binding of the probe

    to the target.

    The initial labeling step is performed before hybridization.

    The various methods of labeling are

    Nick translation

    Random hexamer priming End labeling

    Polymerase chain reaction

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    63/133

    For autoradiographyradioactive labeled probes.

    Nonradioisotope labeling (digoxigenin or biotin) - Offers safe work

    environment, faster signal detection and are easier to use than

    radiolabeled probes.

    Digoxigenin labeled probes - detected with alkaline phosphatase

    conjugated, anti digoxygenin antibody.

    Biotin labeled probes - detected by use of a streptavidin alkaline

    phosphatase conjugate system.

    A third method for visualization is through chemiluminescence, which

    can be detected either luminometrically or on photographic film.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    64/133

    PCR is an exponentially progressing synthesis of the defined target

    DNA sequences in vitro.

    Was introduced in 1983 by Kary mullis for which he received

    Nobel prize in 1993 in chemistry.

    Through this, a single piece of DNA can be used to generate infinite

    supply of identical copies for a variety of research, clinical, forensic

    and commercial purposes.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    65/133

    1) Target DNA - contains the sequence to be amplified.2) Pair of Primers - oligonucleotides that define the sequenceto be amplified.

    4) Thermostable DNA Polymerase - enzyme that catalyzes thereaction (Taq Polymerase)

    5) Mg++

    ions - cofactor of the enzyme

    6) Buffer solution maintains pH and ionic strength of thereaction solution suitable for the activity of the enzyme

    3) dNTPs - deoxynucleotidetriphosphates: DNA building blocks.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    66/133

    THERMOCYCLERPCR tube

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    67/133

    Denature (heat to 95oC)

    Lower temperature to 56oCAnneal with primers

    Increase temperature to 72oC

    DNA polymerase + dNTPs

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    68/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    69/133

    Classification of organisms Genotyping Molecular archaeology Mutagenesis

    Mutation detection Sequencing Cancer research Detection of pathogens DNA fingerprinting

    Drug discovery Genetic matching Genetic engineering Pre-natal diagnosis

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    70/133

    Basic Research Applied Research

    Genetic matching Detection of pathogens Pre-natal diagnosis DNA fingerprinting

    Gene therapy

    Mutation screening Drug discovery Classification of organisms Genotyping

    Molecular Archaeology Molecular Epidemiology Molecular Ecology Bioinformatics Genomic cloning Site-directed mutagenesis

    Gene expression studies

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    71/133

    1. Reverse transcription PCR,2. Nested PCR,3. In situ PCR,4. Competitive PCR,5.

    Single cell PCR,6. Immuno PCR,7. Inverse PCR,8. Anchored PCR,9. Asymmetrical PCR

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    72/133

    Refers to the pairing of complementary RNA or DNA strands to

    produce a double stranded nucleic acid.

    All hybridization methods use a radio labeled DNA or RNA probe

    that binds to the target DNA or RNA of interest, permitting

    visualization.

    The target molecule can be either immobilized in a membrane

    (blotting) or examined in tissue sections (in situ).

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    73/133

    This method was first described by Southern in 1975.

    This involves the transfer or blotting of DNA fragments onto a

    membrane.

    Southern blotting is a technique which allows the detection of a

    specific DNA sequence (gene or other) in a large, complex sample

    of DNA (e.g. cellular DNA).

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    74/133

    Whatman 3mm paper is the worlds most widely used blottingpaper. This acceptance and usage is due to the high quality, purityand consistency that are relied upon by researchers doing Southern,Northern and Western transfers.

    A medium thickness paper (0.34 mm) is used extensively inelectrophoresis for lifting of sequencing gels.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    75/133

    Filter Paper

    Another Filter paper

    Gel Matrix

    Nitrocellulose membrane

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    76/133

    Cut two pieces of filter paper and a piece of nitrocellulosemembrane to an appropriate size, and soak them in transfer buffer.

    Place a piece of buffer soaked filter paper over the gel.

    Flip the gel over, Place the buffer soaked nitrocellulose membraneagainst the exposed gel.

    Place the second piece of buffer soaked filter paper on the

    nitrocellulose membrane (covering it)

    Check to see that there are no bubbles between the membrane andthe gel.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    77/133

    1. The mixture of molecules is separated.

    2. The molecules are immobilized on a matrix.

    3. The probe is added to the matrix to bind to the molecules.

    4. Any unbound probes are then removed.

    5. The place where the probe is connected corresponds to the

    location of the immobilized target molecule.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    78/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    79/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    80/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    81/133

    Gene discovery

    Mapping

    Evolution

    Development studies

    Diagnostics and forensics.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    82/133

    Is an RNA blotting technique which was developed in 1977 by

    Alwine et al.

    It was named after the Southern blotting technique.

    Northern blot analysis allows a direct comparison of the messenger

    RNA abundance between samples on a single membrane.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    83/133

    1. RNA is isolated from several biological samples (e.g. various tissues,various developmental stages of same tissue etc.)RNA is more susceptible to degradation than DNA.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    84/133

    2. Samples are loaded on gel and the RNA samples are separatedaccording to their size on an agarose gel.

    The resulting gel following after the electrophoresis run.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    85/133

    3. The gel is then blotted on a nylon membrane or a nitrocellulosefilter paper by creating the sandwich arrangement.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    86/133

    4. The membrane is placed in a dish containing hybridization bufferwith a labeled probe.

    5. The membrane is washed to remove unbound probe.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    87/133

    6. The labeled probe is detected via autoradiography or via achemiluminescence reaction (if a chemically labeled probe isused). In both cases this results in the formation of a dark band onan X-ray film.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    88/133

    A standard for the direct study of gene expression at the level of mRNA

    (messenger RNA transcripts).

    Detection of mRNA transcript size

    Study RNA degradation Study RNA splicing - can detect alternatively spliced transcripts

    Study RNA half-life

    Study IRES (internal ribosomal entry site) - to remove possibility of RNA

    digestion vs. 2nd cistron translation.

    Often used to confirm and check transgenic / knockout mice (animals)

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    89/133

    Often radioactivity is used. This prevents ease of performing it, use and

    disposal.

    The whole process of northern blotting takes a long time usually, from

    sample preparation through to detection.

    If RNA samples are even slightly degraded by RNases, the quality of the

    data and quantization of expression is quite negatively affected.

    The standard northern blot method is relatively less sensitive than nuclease

    protection assays and RT-PCR. Detection with multiple probes is a problem. Often, the membranes must

    be stripped before hybridization and detection with a second probe.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    90/133

    Is a similar technique used to identify and locate proteins based ontheir ability to bind to specific antibodies.

    Western Blot gives information on the: size of protein & expressionamount of protein.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    91/133

    Steps :1. A protein sample is subjected to electrophoresis on anSDS-polyacrylamide gel.2. Electro blotting transfers the separated proteins from thegel to the surface of a nitrocellulose membrane.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    92/133

    3. The blot is incubated with a generic protein (such as milk proteins)which binds to any remaining sticky places on the nitrocellulose.

    4. An antibody that is specific for the protein of interest (the primaryantibody - Ab1) is added to the nitrocellulose sheet and reacts withthe antigen.

    Only the band containing the protein of interest binds theantibody, forming a layer of antibody molecules .

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    93/133

    5. Following several rinses for removal of non-specifically bound Ab1,the Ab1-antigen complex on the nitrocellulose sheet is incubatedwith a second antibody (Ab2), which specifically recognizes the Fcdomain of the primary antibody and binds it.

    Ab2 is radioactively labeled, or is covalentlylinked to a reporter enzyme, which allows tovisualize the protein-Ab1-Ab2 complex.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    94/133

    The confirmatory HIV test employs a Western blot to detect anti-

    HIV antibody in a human serum sample.

    A Western blot is also used as the definitive test for Bovine

    spongiform encephalopathy (BSE, commonly referred to as 'mad

    cow disease').

    Some forms of Lyme disease testing employ Western blotting.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    95/133

    Is a technique used to examine DNA and RNA in their normaltopographic surroundings.

    In situ hybridization presents a unique set of problems as thesequence to be detected will be at a lower concentration, be maskedbecause of associated protein, or protected within a cell or cellularstructure.

    Therefore, in order to probe the tissue or cells of interest one has to

    increase the permeability of the cell and the visibility of thenucleotide sequence to the probe without destroying the structuralintegrity of the cell or tissue.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    96/133

    a) Frozen sections - Fresh tissue is snap frozen (rapidly put into a -80

    freezer) and then frozen embedded in a special support medium for

    thin cryosectioning. The sections are lightly and rapidly fixed in 4%

    paraformaldehyde just prior to processing for hybridization.b) Paraffin embedded sections - Sections are fixed in formalin as one

    would normally fix tissues for histology and then embedded in wax

    (paraffin sections) before being sectioned

    c) Cells in suspension - Cells can be cytospun onto glass slides and

    fixed with methanol

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    97/133

    Oligonucleotide probes

    Single stranded DNA probes.

    Double stranded DNA probes

    RNA probes (cRNA probes or riboprobes)

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    98/133

    A process which vividly paints chromosomes or portions ofchromosomes with fluorescent molecules.

    Identifies chromosomal abnormalities.

    Aids in gene mapping, toxicological studies, analysis ofchromosome structural aberrations, and ploidy determination.

    Used to identify the presence and location of a region of DNA or

    RNA within morphologically preserved chromosome preparations,fixed cells or tissue sections.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    99/133

    Advantage:

    Less labor-intensive method for confirming the presence of a DNA

    segment within an entire genome than other conventional methods

    like Southern blotting.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    100/133

    Denature the chromosomes

    Denature the probe

    Hybridization

    Fluorescence staining

    Examine slides or store in the dark

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    101/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    102/133

    Detection of high concentrations of base pairs.

    Also used in germ cell or prenatal diagnosis of conditions such as

    aneuploidies.

    Telomeric probes define the terminal boundaries of chromosomes. Used in research of chromosomal rearrangements and deletions

    related to cell aging or other genetic abnormalities.

    Application in cytogenetics - can detect submicroscopic deletions

    and cryptic translocations of genes associated with unexplainedmental retardation and miscarriages.

    FISH can be used in the study of transgenic animals.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    103/133

    In 1986, Hector Battifora first introduced the so-called sausage orMulti Tumor Tissue Block, where up to 100 separate tissues wereprocessed together in one single paraffin wax block.

    Also known as DNA Chip.

    Allows simultaneous measurement of the level of transcription forevery gene in a genome (gene expression).

    Microarray detects mRNA, or rather the more stable cDNA

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    104/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    105/133

    Start with individual genes, e.g. the ~6,200 genes of the yeast

    genome.

    Amplifyall of them using polymerase chain reaction (PCR).

    Spot them on a medium, e.g. an ordinary glass microscope

    slide.

    Each spot is about 100 m in diameter. Spotting is done by a robot.

    Complex and potentially expensive task.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    106/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    107/133

    Ngai Lab arrayer , UC Berkeley Print-tip head

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    108/133

    Building the chip:

    MASSIVE PCR PCR PURIFICATIONAND PREPARATION

    PREPARING

    SLIDES PRINTING

    RNA preparation:CELL CULTURE

    AND HARVEST

    RNA ISOLATION

    cDNA PRODUCTION

    Hybing the chip:

    ARRAY HYBRIDIZATION

    PROBE LABELING DATA ANALYSIS

    POST PROCESSING

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    109/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    110/133

    Pins collect cDNAfrom wells

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    111/133

    384 wellplate

    Contains cDNAprobes

    Glass Slide

    Array of bound cDNA probes

    4x4 blocks = 16 print-tip group

    Print-tip

    group 6

    cDNA clonesSpotted in duplicate

    Print-tipgroup 1

    from wells

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    112/133

    Measuring transcript abundance (cDNA arrays);

    Genotyping;

    Estimating DNA copy number (CGH);

    Determining identity by descent (GMS);

    Measuring mRNA decay rates;

    Identifying protein binding sites;

    Determining sub-cellular localization of gene products;

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    113/133

    Flow cytometry is a technology that simultaneouslymeasures and thenanalyzes multiple physical characteristics of single particles, usually

    cells, as they flow in a fluid stream through a beam of light. The

    properties measured include a particles relative size, relative

    granularity or internal complexity, and relative fluorescence intensity.

    These characteristics are determined using an optical-to-electronic

    coupling system that records how the cell or particle scatters incident

    laser light and emits fluorescence.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    114/133

    Cytometry Localization of antigen is

    possible Poor enumeration of cell

    subtypes

    Limiting number ofsimultaneous measurements

    Flow Cytometry Cannot tell you where

    antigen is. Can analyze many cells in a

    short time frame.

    Can look at numerousparameters at once.

    Instrument Overview

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    115/133

    LASER SOURCE

    Fluidic system

    DetectorOptical filters

    Computer

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    116/133

    Interrogation Point

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    117/133

    When a solution is injected into a flow cytometer the particles are

    randomly distributed in three-dimensional space.

    The sample must therefore be ordered into a stream of single

    particles. That can be interrogated by the machines detection

    system. This process is managed by the fluidics system.

    Hydrodynamic Focusing

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    118/133

    Here we see how the sample is

    transported through the interrogation

    point. For accurate data collection, it is

    important that particles or cells are

    passed through the laser beam one at

    a time.

    Sheath fluidCentral Core

    Single flow

    y y g

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    119/133

    After hydrodynamic focusing, each particle passes through beamsof light.

    The laser are the most commonly used light sources in modern flow

    cytometry.

    It gives information about the particles by forward scatteringChannel and Side scattering channel.

    The detectors used in flow cytometry is PhotomultiplierTube(PMTs).

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    120/133

    As a cell passes through the laser, itwill refract or scatter light at all

    angles.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    121/133

    In most cytometers, a blocking bar

    (called an obscuration bar) is placed in

    front of the forward scatter detector.

    The obscuration bar prevents any of

    the intense laser light from reaching

    the detector. As a cell crosses the

    laser, light is scattered around the

    obscuration bar and is collected by thedetector.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    122/133

    Small cells produce a smallamount of forward scatter andlarge cells produce a largeamount of forward scatter, themagnitude of the voltage pulserecorded for each cell isproportional to the cell size.

    Side Scatter

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    123/133

    The side scatter channel (SSC) provides information about the

    granular content within a particle.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    124/133

    This side-scattered light is focusedthrough a lens system and is collected bya separate detector, usually located 90

    degrees from the lasers path.The signals collected by the side-scatterdetector

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    125/133

    The fluorescent light travelsalong this path, it is directedthrough a series of filters andmirrors, so that particularwavelength ranges aredelivered to the appropriatedetectors.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    126/133

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    127/133

    When light hits a photo detector a small current (a few

    microamperes) is generated.

    Its associated voltage has an amplitude proportional to the total

    number of light photons received by the detector.

    This voltage is then amplified by a series of linear or logarithmic

    amplifiers, and by analog to digital convertors (ADCs), into

    electrical signals large enough (510 volts) tobe plottedgraphically.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    128/133

    Support a diagnosis of malignancy when the morphologic

    changes are equivocal

    Subclassify lesions of borderline malignancy

    Provide prognostic information independent of stage and

    grade

    Monitor response to therapy

    Establish development of tumor relapse

    Establish the origin of synchronus or metachronus tmors

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    129/133

    Neoplasia

    Infectious disease

    Hereditary disease

    Identity determination

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    130/133

    The practice of pathology is currently undergoing significant change, inlarge part due to advances in the analysis of DNA, RNA, and proteins intissues.

    These advances have permitted improved biologic insights into manydevelopmental, inflammatory, metabolic, infectious, and neoplastic

    diseases. Moreover, molecular analysis has also led to improvements in the

    accuracy of disease diagnosis and classification. It is likely that, in thefuture, these methods will increasingly enter into the day-to-day diagnosisand management of patients.

    The pathologist will continue to play a fundamental role in diagnosis andwill likely be in a pivotal position to guide the implementation andinterpretation of these tests as they move from the research laboratory intodiagnostic pathology.

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    131/133

    ABC of clinical genetics by Helen M Kingston

    Textbook of surgical pathology by Ackerman

    Advanced diagnostic methods in oral and maxillofacial pathology:

    molecular methods: journal of oral surg, oral med,oral path: dec 2001

    Textbook of diagnostic molecular pathology

    www.molecularstation.com

    Textbook of oral pathology by Shafer

    Advances in detection and diagnosis of oral precancerous and cancerouslesion: clinic of north America 2006

    http://www.molecularstation.com/http://www.molecularstation.com/http://www.molecularstation.com/http://www.molecularstation.com/http://www.molecularstation.com/http://www.molecularstation.com/
  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    132/133

    Application of cytology and molecular biology in diagonising malignant

    oral lesions: molecular cancer 2006

    Role of oral health care specialists in the diagnostic purpose of oral cancer:M Akhar; AEGIS series

    Review of oral premalignant lesions: Crit Rev Biol Med 2003

    Nomenclature precancer: Journal of oral pathology medicine 2007

    http://teachline.ls.huji.ac.il/72320/methods-tutorial/western/western-

    blot.html

    http://www.bio.davidson.edu/COURSES/GENOMICS/method/westernblot.html

  • 8/2/2019 Diagnostics of Precancerous and Cancerous Lesions

    133/133

    http://www.bio.davidson.edu/COURSES/GENOMICS/method/Southernblot.html

    http://www.med.unc.edu/pmbb/MBT2000/Northern%20Blotting.htm\

    http://www.bme.gatech.edu/vcl/WesternBlotting/Background/Introduction.

    htm